Brief: Cipher Pharmaceuticals receives Health Canada approval of Ozanex
08/05/2017 12:00
May 8 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* Cipher Pharmaceuticals receives health canada approval of
Ozanex (ozenoxacin cream 1pct)
* Cipher Pharmaceuticals Inc - Health Canada approval of
ozanex (ozenoxacin cream, 1pct)
Source text for Eikon: ID:nCNWJhXXCa
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million